NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/15/2023
Back to search
Official data from USPTO
PFIZER DERMATOLOGY PATIENT ACCESS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
08/15/2023
Trademark type
Combined
Nice classes
35
Filing date
12/17/2020
Registration date
08/15/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2023
Last transaction
08/15/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/31/2022
First use in commerce
12/31/2022
Drawing code
3
Owner type
03
Owner location
New York, NY, US
Examiner
SMITH, BRIDGETT G
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word PFIZER DERMATOLOGY PATIENT ACCESS with the first letter "A" of the word Access being a stylized lock.
Holders and representatives
Holders
P. A. (pessoa física)
Representatives
Heather A. McDonald Pfizer Inc.
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Administration of a program for enabling patients to obtain discounts on prescription drug spending through a copay discount program
Publications
History of USPTO decisions and trademark events.
40 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/15/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/12/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/11/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/10/2023
EX3G
SOU EXTENSION 3 GRANTED
07/10/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/10/2023
IUAF
USE AMENDMENT FILED
06/29/2023
EXT3
SOU EXTENSION 3 FILED
06/29/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/29/2023
EISU
TEAS STATEMENT OF USE RECEIVED
06/29/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/28/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/28/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/28/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/28/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/28/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/22/2022
EX2G
SOU EXTENSION 2 GRANTED
12/20/2022
EXT2
SOU EXTENSION 2 FILED
12/20/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/20/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/23/2022
EX1G
SOU EXTENSION 1 GRANTED
06/21/2022
EXT1
SOU EXTENSION 1 FILED
06/21/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/21/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/11/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/16/2021
PUBO
PUBLISHED FOR OPPOSITION
11/16/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/27/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/13/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/06/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/22/2021
GNRT
NON-FINAL ACTION E-MAILED
04/22/2021
CNRT
NON-FINAL ACTION WRITTEN
04/22/2021
DOCK
ASSIGNED TO EXAMINER
04/15/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/27/2021
NWAP
NEW APPLICATION ENTERED
12/21/2020
Continuous trademark protection
Get notified about every new filing that threatens PFIZER DERMATOLOGY PATIENT ACCESS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.